Home Starton Therapeutics

Starton Therapeutics

In operation
-
Transdermal Patch Technology Developer
Basic
Enterprise Profile

Basic Information

Starton Therapeutics, Inc., Focused on Hematology and Oncology, is a Biotechnology Company Dedicated to Changing the Standard of Care Therapies. The Company Has Developed a Transdermal Patch Technology for the Management of Chemotherapy-Induced Nausea and Vomiting.
Starton Holdings, Inc.
NewJersey,United States of America
15~50 people
January 01, 2017
investors@startontx.com

Enterprise Profile

Industrial Sector
Medical Device R&D and Design Biological Drug Production
Concept
Tumor Hematologic Diseases
Application Scenarios
Biologics Generic Drug Medical Device Consumables